PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 24 filers reported holding PSYCHEMEDICS CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $311,141 | -12.9% | 78,373 | 0.0% | 0.01% | -11.1% |
| Q2 2023 | $357,380 | -13.1% | 78,373 | 0.0% | 0.01% | -25.0% |
| Q1 2023 | $411,457 | +118134.8% | 78,373 | +10.5% | 0.01% | +20.0% |
| Q4 2022 | $348 | -99.9% | 70,916 | -12.2% | 0.01% | -37.5% |
| Q3 2022 | $520,000 | +1.6% | 80,728 | 0.0% | 0.02% | +14.3% |
| Q2 2022 | $512,000 | -8.1% | 80,728 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $557,000 | -8.4% | 80,728 | -6.7% | 0.01% | 0.0% |
| Q4 2021 | $608,000 | -25.8% | 86,534 | -11.2% | 0.01% | -33.3% |
| Q3 2021 | $819,000 | +20.6% | 97,444 | 0.0% | 0.02% | +16.7% |
| Q2 2021 | $679,000 | +28.4% | 97,444 | +14.0% | 0.02% | +20.0% |
| Q1 2021 | $529,000 | +21.6% | 85,450 | 0.0% | 0.02% | +7.1% |
| Q4 2020 | $435,000 | +12.7% | 85,450 | -2.3% | 0.01% | -6.7% |
| Q3 2020 | $386,000 | -22.6% | 87,440 | -2.8% | 0.02% | -28.6% |
| Q2 2020 | $499,000 | -5.1% | 89,930 | +3.5% | 0.02% | -12.5% |
| Q1 2020 | $526,000 | -7.2% | 86,918 | +40.3% | 0.02% | +14.3% |
| Q4 2019 | $567,000 | +213.3% | 61,945 | +211.9% | 0.02% | +162.5% |
| Q3 2019 | $181,000 | – | 19,861 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 274,418 | $1,089,439 | 0.78% |
| WEALTH EFFECTS LLC | 40,701 | $161,582 | 0.08% |
| Cannell Capital | 74,794 | $296,932 | 0.07% |
| SANTA MONICA PARTNERS LP | 20,000 | $79 | 0.06% |
| RBF Capital, LLC | 144,231 | $572,597 | 0.04% |
| WEDBUSH SECURITIES INC | 42,414 | $168 | 0.01% |
| Ancora Advisors LLC | 78,373 | $311,141 | 0.01% |
| Your Advocates Ltd., LLP | 1,400 | $5,558 | 0.00% |
| CRAWFORD INVESTMENT COUNSEL INC | 32,098 | $127,428 | 0.00% |
| Renaissance Technologies | 273,663 | $1,086 | 0.00% |